德奎尔韦恩肌炎的管理:系统性审查和网络元分析
Dimitris Challoumas1, Rohan Ramasubbu1, Elliot Rooney1
1School of Infection and Immunity, College of Medicine, Veterinary and Life Sciences, University of Glasgow, Glasgow, Scotland.
JAMA network open
|October 27, 2023
概括
在皮质类固醇注射中添加指香料固定,为德奎尔温紧突炎提供了最小的功能益处. 这种组合可以被视为一线治疗,尽管临床意义有限.
科学领域:
- 肌肉骨医学 肌肉骨医学
- 整形外科手术 整形外科手术
- 物理疗法物理治疗
背景情况:
- 德·奎尔温紧肌炎 (DQT) 提供了许多治疗选择,但有效性数据有限.
- 缺乏明确的管理指南,阻碍了对DQT患者的最佳护理.
研究的目的:
- 系统地评估和比较各种DQT治疗的有效性.
- 为肌肉骨医生提供指导,并为DQT管理提供临床指南.
主要方法:
- 在多个数据库中对DQT干预的随机临床试验 (RCT) 进行了全面的搜索.
- 进行双对和网络元分析以评估疼痛 (VAS) 和功能 (Q-DASH) 结果.
- 使用既有工具评估偏见风险和证据确定性.
主要成果:
- 包括30项研究 (1663名患者);19项进行了定量分析.
- 皮质类固醇注射 (CSI) 随着3-4周的指 Spica 固定化,在统计学上显示,但不是临床上,显著的短期和中期功能改善.
- 超声波导向的CSI在缓解疼痛方面排名最高;CSI加固定显示功能改善的概率最高.
结论:
- 在CSI中添加短期指动不动,在统计上,但不是在临床上,为DQT提供了显著的好处.
- 建议在CSI之后进行3-4周的固定治疗,作为DQT的潜在一线治疗.
相关概念视频
Rheumatic Heart Disease III: Medical Management
11
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
11
Pericarditis III: Medical Management
13
The primary objectives of managing pericarditis are to determine the underlying cause, provide effective therapy for treatment and symptom relief, and promptly detect signs and symptoms of cardiac tamponade. The following outlines the essential aspects of medical management for pericarditis:ObjectivesDetermine the Cause: Identifying the underlying cause of pericarditis is crucial for targeted treatment. Causes include viral infections, autoimmune diseases, post-cardiac injury syndrome, and...
13
Myasthenia Gravis: Overview and Treatment
1.5K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.5K
Rheumatic Heart Disease IV: Nursing Management
15
AssessmentA comprehensive assessment is essential in managing a patient with rheumatic heart disease (RHD). Begin with obtaining a detailed medical history, including recent streptococcal infections, a history of rheumatic fever, or previously diagnosed rheumatic heart disease. Assess the patient for symptoms such as fever, chest pain, widespread joint pain (arthralgia), tachycardia, pericardial friction rub, muffled heart sounds, heart murmurs, peripheral edema, subcutaneous nodules, and...
15
Myocarditis III: Medical Management
7
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
7
Atherosclerosis III: Management
11
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
11


